Bayer Schering Pharma

Nieuws

Mission Statement

Corporate Compliance

Publicaties

Vacatures

Bayer Schering Pharma krijgt toestemming van Europese autoriteiten om Gadovist 1.0 bij kinderen te gebruiken

Bayer Schering Pharma AG successfully completed the procedure for securing approval to use the contrast medium Gadovist® 1.0 in children aged seven and above in Europe's main markets. Germany will start to introduce Gadovist® 1.0 for this new indication in January of this year. In addition, the Swiss Regulatory Authorities have approved Gadovist® 1.0 for the use in children aged 2 years and older. 

Lees het volledige bericht op: http://www.presse.bayer.de/baynews/baynews.nsf/id/8C236BA956E821CAC12576A80057C0D7?Open&ccm=001.